Korean guideline of desmopressin for the treatment of nocturia in men.
Eu Chang HwangHyun Jin JungMi-Ah HanMyung Ha KimSeong Hyeon YuHyun Cheol JeongJun Seok KimSung Hyun PaickJeong Kyun YeoJae Hung Jungnull nullPublished in: Investigative and clinical urology (2022)
The guidelines development panel suggests desmopressin for men with nocturia instead of placebo, behavior modification, or alpha-blocker monotherapy (low certainty of evidence, weak recommendation). Additionally, the panel suggests desmopressin combination therapy with alpha-blockers for men with nocturia instead of alpha-blocker monotherapy or alpha-blocker combination therapy with anticholinergic agents (low certainty of evidence, weak recommendation).